Mynxgrip

Under ultrasound guidance, typical TFA UAE was performed by placement of a 5F vascular access sheath, through which a 5F RIM catheter (Angiodynamics, Latham, NY) was advanced to the contralateral internal iliac artery. Through this, a 3F Renegade Hi-Flo microcatheter was advanced (Boston Scientific, Natick, MA) and used to select the uterine artery (Figure 2). Embolization was performed using 500-700 micron particles to stasis.
At the termination of the procedure, an arteriogram was conducted to assess for femoral artery patency. Following this, the catheter and sheath were removed, and full haemostasis was achieved by placement of either of the following vascular closure devices: MYNXGRIP (Cardinal Health, Dublin, OH), STARCLOSE (Abbott Vascular, Chicago, IL), or ANGIO-SEAL (Terumo, Somerset, NJ). The patient was then transferred to the recovery area with his/her lower extremity straightened for 2 hours before discharge.

Using US guidance, the right common femoral artery was accessed with a 21-gauge needle through which a 5F vascular access sheath was advanced. A Simmons one hydrophilic glidecath (Terumo, Tokyo Japan) was then carried through this to the proper hepatic artery. Subsequently, a Renegade Hi-Flo microcatheter was advanced (Boston Scientific, Natick MA), and used for sub-selective branch therapy [Figure 2]. Typical femoral vascular access closure was obtained by either STARCLOSE (Abbott Vascular, Chicago, IL), MYNXGRIP (Cardinal Health, Dublin, OH), ANGIO-SEAL (Terumo, Somerset, NJ) or manual compression. The patient was then transferred to the recovery area with their lower extremity straight for 2 hours before discharge.

Using ultrasound, the right common femoral artery was accessed with a 21gauge needle and a small skin incision was made at the puncture site. The needle was exchanged for a 5 French transitional micropuncture sheath over an 0.018-in nitinol wire. The micropuncture sheath was then exchanged for a 5 French × 10 cm vascular sheath over a 0.035-in × 145 cm Coons wire.
At the termination of the procedure, an arteriogram was conducted to assess for femoral artery patency. Following this, the catheter and sheath were removed and full hemostasis was achieved by placement of either of the following vascular closure devices: MYNXGRIP (Cardinal Health, Dublin, OH), STARCLOSE (Abbott Vascular, Chicago, IL) or ANGIO-SEAL (Terumo, Somerset, NJ). The patient was then transferred to the recovery area with his/her lower extremity straightened for 2 hours before discharge.